CASI Pharmaceuticals (NASDAQ:CASI) Now Covered by StockNews.com
StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report released on Thursday. The firm issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Stock Performance Shares of CASI opened at $2.20 on Thursday. The firm has a fifty day moving average of $2.39 and a 200-day […]
